| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 64.37▼ | 64.56▼ | 64.51▼ | 64.92▼ | 65.50▼ |
| MA10 | 64.48▼ | 64.63▼ | 64.79▼ | 65.14▼ | 63.76▲ |
| MA20 | 64.59▼ | 64.96▼ | 64.96▼ | 65.41▼ | 59.97▲ |
| MA50 | 64.63▼ | 64.89▼ | 65.19▼ | 63.68▲ | 57.74▲ |
| MA100 | 64.85▼ | 65.20▼ | 65.44▼ | 59.44▲ | 59.78▲ |
| MA200 | 65.08▼ | 65.39▼ | 66.39▼ | 58.31▲ | 75.05▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.061▼ | -0.084▼ | -0.093▼ | -0.345▼ | 0.617▲ |
| RSI | 20.165▼ | 28.198▼ | 34.255▼ | 45.699▼ | 58.258▲ |
| STOCH | 10.599▼ | 22.465 | 8.736▼ | 37.639 | 64.068 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -91.123▼ | -42.105 |
| CCI | -311.198▼ | -240.599▼ | -144.652▼ | -108.105▼ | 54.191 |
|
Friday, September 18, 2026 10:02 AM
BioMarin Pharmaceutical (NASDAQ:BMRN) said it is progressing with the integration of Amicus Therapeutics while pursuing additional business-development opportunities, as executives outlined growth ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/09/26 | 65.25 | 65.29 | 63.84 | 63.94 | 4,455,803 |
| 17/09/26 | 65.34 | 66.21 | 64.97 | 65.08 | 1,362,522 |
| 16/09/26 | 64.48 | 65.67 | 64.34 | 64.73 | 2,252,492 |
| 15/09/26 | 65.78 | 65.78 | 63.85 | 64.45 | 1,847,943 |
| 14/09/26 | 66.27 | 66.88 | 65.72 | 66.41 | 1,335,978 |
| 11/09/26 | 65.96 | 66.05 | 65.285 | 65.68 | 1,603,759 |
| 10/09/26 | 64.41 | 65.59 | 63.5742 | 65.51 | 2,182,427 |
| 09/09/26 | 63.83 | 65.325 | 63.64 | 64.41 | 1,882,606 |
| 08/09/26 | 65.24 | 66.26 | 64.01 | 64.63 | 1,457,213 |
| 04/09/26 | 65.785 | 66.64 | 65.52 | 66.53 | 2,299,149 |
|
|
||||
|
|
||||
|
|